← Back to Search

Omega-3 for Loss of Smell

Phase 2
Waitlist Available
Led By Alfred-Marc Iloreta, MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, weeks 1, 2, 4 and 6 after softgel initiation

Summary

This trial is testing whether taking omega-3 supplements can help people who have lost their sense of smell due to COVID-19. The study focuses on patients with this specific issue because it affects their quality of life. Omega-3 supplements might help by protecting and repairing the nerves involved in smelling. Omega-3 fatty acids have been shown to enhance immune response, reduce inflammation, and improve symptoms in patients with COVID-19.

Eligible Conditions
  • Loss of Smell
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, weeks 1, 2, 4 and 6 after softgel initiation
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, weeks 1, 2, 4 and 6 after softgel initiation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Brief Smell Identification Test (BSIT)
Change in Brief Smell Identification Test (BSIT) in Participants With Laboratory-Confirmed COVID-19
Change in Brief Smell Identification Test (BSIT) in Participants With Laboratory-Confirmed COVID-19 and Severe Olfactory Dysfunction
+1 more
Secondary study objectives
Modified Brief Questionnaire of Olfactory Dysfunction (mQOD-NS)
Sinonasal Outcomes Test (SNOT-22)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Omega-3Active Control1 Intervention
1,000 mg of omega-3 fatty acid (2 softgels per day for 6 weeks)
Group II: Placebo/ControlPlacebo Group1 Intervention
2 softgels per day for 6 weeks

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
904 Previous Clinical Trials
541,666 Total Patients Enrolled
Alfred-Marc Iloreta, MD4.918 ReviewsPrincipal Investigator - Icahn School of Medicine at Mount Sinai
The Mount Sinai Hospital, The New York Eye and Ear Infirmary, Mount Sinai West
Medical School - University of Kansas, Doctor of Medicine
Mount Sinai Hospital, Residency in Otolaryngology
2 Previous Clinical Trials
67 Total Patients Enrolled
3Patient Review
The wait for medication was far too long — nearly three days. And even now, trying to get in touch with them has been difficult.
~26 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top